Ethosuximide plus pentoxifylline for IBS belly pain
Part of Digestive system clinical trials.
This Phase 3 study tests whether two medicines (ethosuximide and pentoxifylline) can reduce belly pain from irritable bowel syndrome (IBS). It may help people whose IBS pain has been moderate to severe recently and who can keep their current IBS treatment steady.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have IBS based on the Rome IV criteria (a specific checklist used to define IBS).
- In the last 7 days, your average belly pain score was 4 or higher out of 10.
- Your IBS treatment has stayed the same for at least 1 month.
- If you can become pregnant: you have a negative pregnancy test and use reliable birth control.
- You are not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining brain stimulation (called transcranial magnetic stimulation) with either a medication or a probiotic can help reduce diarrhea and belly pain in people with IBS. If you join, you'll receive one of these combinations to see if it improves your symptoms.
This trial tests whether psilocybin-assisted psychotherapy can help people with severe irritable bowel syndrome (IBS) who have not gotten better with standard treatments. Psilocybin is a psychedelic substance that may help reset brain-gut connections to reduce symptoms.
This trial tests whether a home device that uses mild skin electrical stimulation can reduce belly pain from IBS with constipation. It also checks whether the treatment is safe and helpful for symptom relief over the study period.
This study tests whether a low-FODMAP diet combined with PEG 3350 can reduce symptoms in adults with IBS-C (irritable bowel syndrome with constipation). It may help improve bowel habits and abdominal pain, and it checks which people can safely follow the diet and treatment plan.
This study tests a new way to measure belly pain in people with IBS using special sensors. It may help doctors better understand and treat your pain.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
Hear when a new IBS - Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.